$ USD
¥ 人民币
$ USD
€ 欧元
English
简体中文
English
繁体中文
Sign In / Sign up
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Menu
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Home
Oncology
Oncology
Oncology_Medical Halo Global Medical Oncology News_Oncology Drug Therapy News
克唑替尼治疗晚期ALK重排非小细胞肺癌并发脑转移
2025-10-19 11:44:20
Check Details
特罗凯治疗肺癌总生存率达到86%
2025-10-19 11:44:20
Check Details
晚期ALK阳性非小细胞肺癌患者进展后继续使用克唑替尼的临床益处
2025-10-19 11:44:20
Check Details
特罗凯治疗中国肺癌患者的效果
2025-10-19 11:44:20
Check Details
艾乐替尼对肺癌脑转移治疗优于克唑替尼
2025-10-19 11:44:20
Check Details
艾乐替尼治疗ALK突变阳性的NSCLC安全有效
2025-10-19 11:44:20
Check Details
泰瑞沙EGFR阳性NSCLC患者一线用药
2025-10-19 11:44:20
Check Details
克唑替尼治疗ALK阳性非小细胞肺癌的活性和安全性:1期研究最新结果
2025-10-19 11:44:20
Check Details
阿法替尼治疗化疗失败的肺鳞癌患者
2025-10-19 11:44:20
Check Details
儿童和老年肺癌患者可以服用艾乐替尼吗?
2025-10-19 11:44:20
Check Details
奥希替尼黑盒和白盒的疗效差异
2025-10-19 11:44:20
Check Details
艾乐替尼一线治疗ALK阳性晚期非小细胞肺癌
2025-10-19 11:44:20
Check Details
1
2
...
3005
3006
3007
3008
3009
3010
3011
...
4153
4154
Category
Oncology
Hepatobiliary
dermatology
Endocrinology
Hematology
Andrology
Gynecology
Nephrology
Urology
Department of Infectious Diseases
Gastroenterology
Respiratory department
Neurology
Cardiology and Brain Department
ophthalmology
Psychiatry
Immunology Department
orthopedics
Burn Department
相关知识
1
Elacestrant: Precision Therapy for ESR1-Mutant Resistant HR+/HER2- Advanced Breast Cancer
2
Selpercatinib Complete Medication Guide: Indications, Dosage and Safety Information for RET Inhibitor
3
Complete Guide to Dosage and Dose Adjustment of Entrectinib
4
Comprehensive Analysis of Bleeding Risk with Tepotinib in MET-Mutated Non-Small Cell Lung Cancer
5
Lomustine vs Temozolomide: Comprehensive Comparison of Efficacy and Safety in Glioma Treatment
6
Tepotinib and Osimertinib: Current Status and Clinical Positioning of Combination Therapy in Non-Small Cell Lung Cancer
7
Tumor Shrinkage Effect and Core Therapeutic Value of Pazopanib
8
Tabrecta (Capmatinib): A Targeted Therapy for METex14-Mutated NSCLC
9
Pazopanib Shows Promise as Second-Line Therapy for Aggressive Skin Cancer
10
Managing Immunotherapy-Related Adverse Events of Tarlatamab-Imdelltra: A Guide to Dual-Specific T Cell Engager Safety
11
Almonertinib Safety Guide: Managing Adverse Reactions in NSCLC Treatment with a 3rd-Gen EGFR TKI
12
Pimitespib Storage Guidelines: Temperature, Humidity & Light Control for Home Use